Open AccessCould soluble L1 cell adhesion molecule (sL1CAM) in serum be a new biomarker for endometrial cancer?
Author(s) -
Emre Sertel,
Merve Demir,
Sare Doğan,
Aydın Çorakçi
Publication year - 2022
Publication title -
ginekologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 21
eISSN - 2543-6767
pISSN - 0017-0011
DOI - 10.5603/gp.a2022.0116
Subject(s) - endometrial cancer , medicine , endometrial hyperplasia , atypical hyperplasia , biomarker , endometrial biopsy , cancer , hyperplasia , endometrial polyp , carcinoma , biopsy , gastroenterology , oncology , gynecology , endometrium , biochemistry , chemistry
The aim of this study is to evaluate the place of serum soluble L1 cell adhesion molecule (sL1CAM) level in the diagnosis of endometrial cancer and its relationship with clinicopathological features.